MBX Biosciences, Inc. Shares Outstanding (Cover Page)
MBX Biosciences, Inc. (MBX) had Shares Outstanding (Cover Page) of 48.16 million shares as of 2026-08-03, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-08-03: Entity Common Stock, Shares Outstanding 48.16M shares.
- 2026-05-04: Entity Common Stock, Shares Outstanding 47.60M shares.
- 2026-03-06: Entity Common Stock, Shares Outstanding 47.51M shares.
- 2025-11-03: Entity Common Stock, Shares Outstanding 44.90M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-08-03 | 48.16M shares 10-Q · filed 2026-08-06 |
| 2026-05-04 | 47.60M shares 10-Q · filed 2026-05-07 |
| 2026-03-06 | 47.51M shares 10-K · filed 2026-03-12 |
| 2025-11-03 | 44.90M shares 10-Q · filed 2025-11-06 |
| 2025-08-04 | 33.59M shares 10-Q · filed 2025-08-07 |
| 2025-05-08 | 33.42M shares 10-Q · filed 2025-05-12 |
| 2025-03-13 | 33.42M shares 10-K · filed 2025-03-17 |
| 2024-11-01 | 33.42M shares 10-Q · filed 2024-11-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |